Alyeska Investment Group
ACHV icon

Alyeska Investment Group’s Achieve Life Sciences ACHV Stock Holding History

Alyeska Investment Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
+1,925,722
New +$9.18M 0.03% 404
2025
Q4 		– Sell
-178,389
Closed -$562K – 581
2025
Q3 		$562K Sell
178,389
-3,325,944
-95% -$9.13M ﹤0.01% 557
2025
Q2 		$7.92M Buy
3,504,333
+3,083,333
+732% +$8.78M 0.03% 379
2025
Q1 		$1.12M Hold
421,000
– – ﹤0.01% 432
2024
Q4 		$1.48M Sell
421,000
-50,000
-11% -$227K 0.01% 477
2024
Q3 		$2.23M Hold
471,000
– – 0.01% 412
2024
Q2 		$2.21M Hold
471,000
– – 0.01% 403
2024
Q1 		$2.14M Buy
+471,000
New +$2.09M 0.01% 372

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Alyeska Investment Group's ACHV Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 1,925,722 shares worth $12.6M. The stake represents 0.03% of the portfolio and ranks #404 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in ACHV as recently as Q3 2025.

Alyeska Investment Group first reported a position in ACHV in Q1 2024 and has held it in 8 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Alyeska Investment Group held 1,925,722 shares of Achieve Life Sciences worth $12.6M as of Q2 2026.
  • Achieve Life Sciences was a new Alyeska Investment Group position in Q2 2026.
  • Achieve Life Sciences made up 0.03% of Alyeska Investment Group's portfolio in Q2 2026, its #404 holding.
  • Alyeska Investment Group first reported a position in Achieve Life Sciences in Q1 2024 and has held it in 8 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.